This medication is typically prescribed for patients medically diagnosed with obesity, though it may also be considered for individuals who are overweight with related health conditions
The severity varies considerably between individuals
P = .004), major adverse cardiovascular events (RR = 0.72
Ethics statement The animal study was reviewed and approved by The Institutional Animal Ethical Committee, Annamalai University
Its comparison table lists a history of pancreatitis and MTC or MEN2 for semaglutide, and describes melatonin contraindications as rare, naming pregnancy and autoimmune conditions
Both drugs share a similar side-effect pattern: nausea, vomiting, diarrhea, and constipation are the most common issues , usually mild to moderate and dose-related though it appears fewer people stop taking tirzepatide due to side effects